|
SLMO2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32419999807365E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55839996462959E-09 |
| Normal-vs-Stage2 |
2.478100E-02 |
| Normal-vs-Stage3 |
2.039500E-04 |
| Normal-vs-Stage4 |
3.176200E-04 |
| Stage1-vs-Stage2 |
1.171590E-01 |
| Stage1-vs-Stage3 |
9.760600E-01 |
| Stage1-vs-Stage4 |
3.682600E-01 |
| Stage2-vs-Stage3 |
2.374200E-01 |
| Stage2-vs-Stage4 |
4.371600E-01 |
| Stage3-vs-Stage4 |
5.641400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39360000042765E-07 |
| Normal-vs-AfricanAmerican |
1.74269487729362E-11 |
| Normal-vs-Asian |
2.291800E-01 |
| Caucasian-vs-AfricanAmerican |
2.984800E-04 |
| Caucasian-vs-Asian |
6.131600E-01 |
| AfricanAmerican-vs-Asian |
1.854750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.35620000019499E-07 |
| Normal-vs-Female |
1.26660000265844E-08 |
| Male-vs-Female |
4.901400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.81400000000198E-05 |
| Normal-vs-Age(41-60Yrs) |
1.6716999995392E-07 |
| Normal-vs-Age(61-80Yrs) |
2.02950000000035E-05 |
| Normal-vs-Age(81-100Yrs) |
1.237560E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.218800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.645810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.296200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.501400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.117800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.376600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.355500E-04 |
| Normal-vs-Grade 2 |
1.64425999999995E-05 |
| Normal-vs-Grade 3 |
3.59279994643913E-09 |
| Normal-vs-Grade 4 |
6.25509999999663E-05 |
| Grade 1-vs-Grade 2 |
1.478980E-01 |
| Grade 1-vs-Grade 3 |
3.744200E-01 |
| Grade 1-vs-Grade 4 |
3.259600E-01 |
| Grade 2-vs-Grade 3 |
4.387400E-01 |
| Grade 2-vs-Grade 4 |
6.718600E-01 |
| Grade 3-vs-Grade 4 |
9.472200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72519999952492E-07 |
| Normal-vs-ccB subtype |
1.079370E-03 |
| ccA subtype-vs-ccB subtype |
4.532800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25669999999178E-05 |
| Normal-vs-N1 |
6.542400E-02 |
| N0-vs-N1 |
7.596000E-01 |
|
|
